73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Cancer biomarker data is not diverse, with implications for immunotherapy patients from underrepresented groups

Cancer biomarker data is not diverse, with implications for immunotherapy patients from underrepresented groups

byCell PressCredit: Pixabay/CC0 Public DomainHigh tumor mutational burden—the number of mutations found inside cancer cells—may not generalize as an accurate biomarker across diverse cancer pati

Cancer biomarker data is not diverse, with implications for immunotherapy patients from underrepresented groups

byCell PressCredit: Pixabay/CC0 Public DomainHigh tumor mutational burden—the number of mutations found inside cancer cells—may not generalize as an accurate biomarker across diverse cancer pati
Point-of-care biosensor rapidly detects oral cancer

Point-of-care biosensor rapidly detects oral cancer

byAmerican Institute of PhysicsPhoto of the group’s circuit board for the biosensor. Credit: Minghan Xian, Jenna L. Stephany, Chan-Wen Chiu, Chao-Cing Chiang, Fan Ren, Cheng-Tse Tsai, Siang-Sin

Point-of-care biosensor rapidly detects oral cancer

byAmerican Institute of PhysicsPhoto of the group’s circuit board for the biosensor. Credit: Minghan Xian, Jenna L. Stephany, Chan-Wen Chiu, Chao-Cing Chiang, Fan Ren, Cheng-Tse Tsai, Siang-Sin
Ketamine's promise for severe depression grows, but major questions remain

Ketamine's promise for severe depression grows, but major questions remain

by University of MichiganCredit: CC0 Public DomainUsing an old anesthesia drug to pull people out of the depths of severe depression has gone from fringe idea to widespread use in just a few year

Ketamine's promise for severe depression grows, but major questions remain

by University of MichiganCredit: CC0 Public DomainUsing an old anesthesia drug to pull people out of the depths of severe depression has gone from fringe idea to widespread use in just a few year
Reprogramming cancer cells into immune defenders

Reprogramming cancer cells into immune defenders

by Tove Smeds,Lund UniversityDolly the sheep determined Filipe Pereira’s future career. The choice was between becoming an architect or a scientist, when one of the world’s most extreme examples

Reprogramming cancer cells into immune defenders

by Tove Smeds,Lund UniversityDolly the sheep determined Filipe Pereira’s future career. The choice was between becoming an architect or a scientist, when one of the world’s most extreme examples
Stop breaking women's hearts at work: 7 ways to make workplaces better for cardiovascular health

Stop breaking women's hearts at work: 7 ways to make workplaces better for cardiovascular health

by Shannan M. Grant, Barb Hamilton-Hinch, Dayna Lee-Baggley, Jacquie Gahagan, Jessica Mannette and Leigh-Ann MacFarlane,The ConversationCredit: Unsplash/CC0 Public DomainProminent heart health m

Stop breaking women's hearts at work: 7 ways to make workplaces better for cardiovascular health

by Shannan M. Grant, Barb Hamilton-Hinch, Dayna Lee-Baggley, Jacquie Gahagan, Jessica Mannette and Leigh-Ann MacFarlane,The ConversationCredit: Unsplash/CC0 Public DomainProminent heart health m
Artificial intelligence tracks down leukemia

Artificial intelligence tracks down leukemia

byGerman Center for Neurodegenerative DiseasesCredit: CC0 Public DomainArtificial intelligence can detect one of the most common forms of blood cancer—acute myeloid leukemia (AML)—with high reli

Artificial intelligence tracks down leukemia

byGerman Center for Neurodegenerative DiseasesCredit: CC0 Public DomainArtificial intelligence can detect one of the most common forms of blood cancer—acute myeloid leukemia (AML)—with high reli
Structural analysis reveals an unexpected mechanism for a cancer drug

Structural analysis reveals an unexpected mechanism for a cancer drug

by Tim Stephens,University of California - Santa CruzThe breast cancer drug palbociclib (grey) interacts with its target protein CDK4 (green) in this structural model. Binding of the activator p

Structural analysis reveals an unexpected mechanism for a cancer drug

by Tim Stephens,University of California - Santa CruzThe breast cancer drug palbociclib (grey) interacts with its target protein CDK4 (green) in this structural model. Binding of the activator p
Routine HPV testing may be warranted for sinonasal cancers

Routine HPV testing may be warranted for sinonasal cancers

(HealthDay)—Only one in four patients with sinonasal squamous cell carcinoma (SNSCC) is tested for human papillomavirus (HPV), according to a study published online Dec. 30 inCancer.Jamie R. Oli

Routine HPV testing may be warranted for sinonasal cancers

(HealthDay)—Only one in four patients with sinonasal squamous cell carcinoma (SNSCC) is tested for human papillomavirus (HPV), according to a study published online Dec. 30 inCancer.Jamie R. Oli
Researchers shed light on cancer drug resistance, potential to expand use of PARP inhibitors across cancer types

Researchers shed light on cancer drug resistance, potential to expand use of PARP inhibitors across cancer types

byThe University of Hong KongInactivation of a DNA repair gene called FANCM enhances the formation of DNA damage and chromosomal instability induced by a PARP inhibitor, leading to massive cance

Researchers shed light on cancer drug resistance, potential to expand use of PARP inhibitors across cancer types

byThe University of Hong KongInactivation of a DNA repair gene called FANCM enhances the formation of DNA damage and chromosomal instability induced by a PARP inhibitor, leading to massive cance
Researchers identify path to prevent cognitive decline after radiation

Researchers identify path to prevent cognitive decline after radiation

by Kelsie Smith Hayduk,University of Rochester Medical CenterCredit: Pixabay/CC0 Public DomainResearchers at the Del Monte Institute for Neuroscience at the University of Rochester find that mic

Researchers identify path to prevent cognitive decline after radiation

by Kelsie Smith Hayduk,University of Rochester Medical CenterCredit: Pixabay/CC0 Public DomainResearchers at the Del Monte Institute for Neuroscience at the University of Rochester find that mic
Falling PSA levels found to predict longer survival in prostate cancer patients at high risk of metastases

Falling PSA levels found to predict longer survival in prostate cancer patients at high risk of metastases

byWolters Kluwer HealthTwelve-month landmark analysis of overall survival (OS) by prostate-specific antigen (PSA) decline subgroup for enzalutamide-treated men. Data cutoff: October 15, 2019. Cr

Falling PSA levels found to predict longer survival in prostate cancer patients at high risk of metastases

byWolters Kluwer HealthTwelve-month landmark analysis of overall survival (OS) by prostate-specific antigen (PSA) decline subgroup for enzalutamide-treated men. Data cutoff: October 15, 2019. Cr
New urine-based test shows promise in making cervical cancer screening more accessible and less invasive

New urine-based test shows promise in making cervical cancer screening more accessible and less invasive

byWaseda UniversityDetection of HPV16 E7 oncoproteins in urine samples using ultrasensitive enzyme-linked immunosorbent assay Image caption: Researchers have now validated a noninvasive method f

New urine-based test shows promise in making cervical cancer screening more accessible and less invasive

byWaseda UniversityDetection of HPV16 E7 oncoproteins in urine samples using ultrasensitive enzyme-linked immunosorbent assay Image caption: Researchers have now validated a noninvasive method f